[AKRO] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
12-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 15.91%
YoY- -13.68%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,403 -26,029 -32,424 -24,330 -28,933 -15,090 -29,711 -5.26%
Tax 297 -22 -11 -51 -50 -50 -11 -
NP -27,403 -26,007 -32,424 -24,330 -28,933 -15,090 -29,711 -5.26%
Tax Rate - - - - - - - -
Total Cost 27,403 26,007 32,424 24,330 28,933 15,090 29,711 -5.26%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.77 -0.74 -0.93 -0.70 -0.83 -0.43 -0.86 -7.12%
EPS Diluted -0.77 -0.74 -0.93 -0.70 -0.83 -0.43 -0.86 -7.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.